The company Polylab is an official distributor of a number of drugs on world markets developed within the framework of innovation projects for biotechnology development.
The experience of the company's experts and partners allows prompt implementation and testing of the most advanced biotechnology developments of both Russian and foreign researchers. The company's scientific base allows it not only to move with the times but also to set the tempo of this movement. Studies and experiments of our scientists in the field of biopharmaceuticals are always of practical importance. We always try to reduce to the minimum the time between the appearance of a new scientific idea and production of a new drug. In the process of our research work, we have created a range of special drugs that are at different stages of readiness to registration.
Development of modern medical science prompts the necessity of synthesis of all scientific knowledge and disciplines to achieve a breakthrough in the field of treatment and prevention of illnesses from which millions of people suffer and which are difficult to treat at the present stage.
The major percentage of illnesses that create difficulties for both patients and clinicians are those prone to chronicity with frequent recurrence and often based on a genetic factor. The fight against these illnesses should become the major challenge of modern medicine concerned with finding new approaches to resolve old problems.